Nucleoside derivatives

Details Nucleoside derivatives Nucleoside derivatives

C - Chemistry, Metallurgy

07

H

C07H 19/06 (2006.01) A61K 31/505 (2006.01) A61K 31/52 (2006.01) A61K 31/70 (2006.01) C07D 239/46 (2006.01) C07D 405/04 (2006.01) C07D 473/00 (2006.01) C07F 9/547 (2006.01) C07F 9/6512 (2006.01) C07F 9/6558 (2006.01) C07F 9/6561 (2006.01) C07H 19/04 (2006.01) C07H 19/10 (2006.01) C07H 19/16 (2006.01) C07H 19/20 (2006.01)

Patent

CA 2093020

2093020 9206102 PCTABS00011 Novel antiviral compounds of formulae (1A) and (1B), wherein X and R1-R4 are as stated in claim 1 in the form of an .alpha.- or .beta.-anomer or a mixture thereof, and pharmaceutically acceptable salts thereof are disclosed, as well as a new method for preparation thereof. Said compounds can be used for treatment of infections caused by viruses requiring reverse transcriptase for replication, such as HIV and hepatitis B virus.

Affiliated with

Also associated with

Rating

Nucleoside derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleoside derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleoside derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1786418